CIRBP and cancer: Given the induction of cancer cell dormancy by DYRK1B in various cancer types (Becker, 2018), we also investigated the interactions between CIRBP and DYRK1B as well as the resulting impacts of these interactions on the tumourigenesis and chemoresistance of PDAC cells.